USA
Guidance on New Animal Drugs Administered in Medicated Feed or Drinking Water of Food Producing Animals
Summary Description
Formulates recommendations to phase out production uses of medically important antimicrobials in food-producing animals to align practices with the FDA's recommendations included in the guidance document "The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals" (Judicious Use Guidance, GFI #209).
Topics
Species
Farmed animals
Jurisdiction
USA
Sub-Jurisdiction
N/A
Type of Act
Policy
Status
In force
Legal Value
Voluntary
Date Enacted
2013
Date Updated
June, 2023
Official Citation
U.S. Food and Drug Administration, Guidance for Industry #213, December 2013 (U.S.A.)
Strengths & Weaknesses
Strengths
- Recommends eliminating the use of medically important antimicrobials for growth promotion and feed efficiency purposes.
- Recommends that all medically important antimicrobials used in feed or water should require a VFD (Veterinary Feed Directive) or a prescription.
Weaknesses
- These recommendations are not binding and as such, have never been codified into law. As a result, the regulations pertaining to antimicrobials use in the US have never been updated to reflect this guidance document.
- Only covers medically important antimicrobials.
- The recommendation that animal pharmaceutical companies should remove growth-promotion claims from medically important antimicrobial drugs in food-producing animals may result in the drugs simply being re-labelled with new "disease-prevention" labels but still be used in the same way.
The Coller Animal Law Forum is part of Jeremy Coller Foundation, a registered charity (No. 1163970) and a company limited by guarantee (No. 9696841) in England and Wales. | Copyright @ 2026